Pirfenidone improves adipose dysfunction and obesity-driven steatohepatitis via mTORC1 signaling
Yu Seol Lee, Ji Yun Bang, Da Hyun Lee, Da Ye Kim, Shin Young Cha, Eo Jin Lee, Jisu Han, Soo Han Bae
This study shows pirfenidone improves adipose dysfunction and obesity-driven steatohepatitis by modulating mTORC1 signaling in different adipose depots.
bioRxiv · Mar 21, 2026 · PreprintMolecular Biology